| Molecular markers of tubulointerstitial fibrosis and tubular cell damage in patients with chronic kidney disease S Nakagawa, K Nishihara, H Miyata, H Shinke, E Tomita, M Kajiwara, ... PloS one 10 (8), e0136994, 2015 | 169 | 2015 |
| Pericyte MyD88 and IRAK4 control inflammatory and fibrotic responses to tissue injury IA Leaf, S Nakagawa, BG Johnson, JJ Cha, K Mittelsteadt, KM Guckian, ... The Journal of clinical investigation 127 (1), 321-334, 2017 | 133 | 2017 |
| Taxanes and platinum derivatives impair Schwann cells via distinct mechanisms S Imai, M Koyanagi, Z Azimi, Y Nakazato, M Matsumoto, T Ogihara, ... Scientific reports 7 (1), 5947, 2017 | 97 | 2017 |
| Involvement of autophagy in the pharmacological effects of the mTOR inhibitor everolimus in acute kidney injury S Nakagawa, K Nishihara, K Inui, S Masuda European journal of pharmacology 696 (1-3), 143-154, 2012 | 82 | 2012 |
| TLR-2/TLR-4 TREM-1 signaling pathway is dispensable in inflammatory myeloid cells during sterile kidney injury G Campanholle, K Mittelsteadt, S Nakagawa, A Kobayashi, SL Lin, ... PloS one 8 (7), e68640, 2013 | 64 | 2013 |
| Urinary chemokine (CC motif) ligand 2 (monocyte chemotactic protein-1) as a tubular injury marker for early detection of cisplatin-induced nephrotoxicity K Nishihara, S Masuda, H Shinke, A Ozawa, T Ichimura, A Yonezawa, ... Biochemical pharmacology 85 (4), 570-582, 2013 | 59 | 2013 |
| Effect of medication adherence on disease activity among Japanese patients with rheumatoid arthritis S Nakagawa, M Nakaishi, M Hashimoto, H Ito, W Yamamoto, ... PLoS One 13 (11), e0206943, 2018 | 32 | 2018 |
| mTOR inhibitor everolimus ameliorates progressive tubular dysfunction in chronic renal failure rats S Nakagawa, S Masuda, K Nishihara, K Inui Biochemical pharmacology 79 (1), 67-76, 2010 | 30 | 2010 |
| Novel 5-fluorouracil-resistant human esophageal squamous cell carcinoma cells with dihydropyrimidine dehydrogenase overexpression O Kikuchi, S Ohashi, Y Nakai, S Nakagawa, K Matsuoka, T Kobunai, ... American journal of cancer research 5 (8), 2431, 2015 | 29 | 2015 |
| Disruption of Slc52a3 gene causes neonatal lethality with riboflavin deficiency in mice H Yoshimatsu, A Yonezawa, K Yamanishi, Y Yao, K Sugano, ... Scientific reports 6, 27557, 2016 | 28 | 2016 |
| Functional involvement of RFVT3/SLC52A3 in intestinal riboflavin absorption H Yoshimatsu, A Yonezawa, Y Yao, K Sugano, S Nakagawa, T Omura, ... American Journal of Physiology-Gastrointestinal and Liver Physiology 306 (2 …, 2013 | 27 | 2013 |
| Accumulation of alpha-fluoro-beta-alanine and fluoro mono acetate in a patient with 5-fluorouracil-associated hyperammonemia Y Nishikawa, T Funakoshi, T Horimatsu, S Miyamoto, T Matsubara, ... Cancer chemotherapy and pharmacology 79, 629-633, 2017 | 22 | 2017 |
| Extracellular nucleotides from dying cells act as molecular signals to promote wound repair in renal tubular injury S Nakagawa, T Omura, A Yonezawa, I Yano, T Nakagawa, K Matsubara American Journal of Physiology-Renal Physiology 307 (12), F1404-F1411, 2014 | 22 | 2014 |
| Impact of Cyclin B2 and Cell division cycle 2 on tubular hyperplasia in progressive chronic renal failure rats K Nishihara, S Masuda, S Nakagawa, A Yonezawa, T Ichimura, ... American Journal of Physiology-Renal Physiology 298 (4), F923-F934, 2010 | 20 | 2010 |
| Association of proton pump inhibitors and concomitant drugs with risk of acute kidney injury: a nested case–control study K Ikuta, S Nakagawa, K Momo, A Yonezawa, K Itohara, Y Sato, S Imai, ... BMJ open 11 (2), e041543, 2021 | 19 | 2021 |
| Schwann cell-derived CXCL1 contributes to human immunodeficiency virus type 1 gp120-induced neuropathic pain by modulating macrophage infiltration in mice M Ntogwa, S Imai, R Hiraiwa, M Koyanagi, M Matsumoto, T Ogihara, ... Brain, behavior, and immunity 88, 325-339, 2020 | 19 | 2020 |
| Pronociceptive roles of schwann cell–derived galectin-3 in taxane-induced peripheral neuropathy M Koyanagi, S Imai, M Matsumoto, Y Iguma, N Kawaguchi-Sakita, ... Cancer research 81 (8), 2207-2219, 2021 | 18 | 2021 |
| Improvement of peripheral vascular impairment by a phosphodiesterase type 5 inhibitor tadalafil prevents oxaliplatin-induced peripheral neuropathy in mice T Ogihara, T Nakagawa, M Hayashi, M Koyanagi, A Yonezawa, T Omura, ... Journal of Pharmacological Sciences 141 (4), 131-138, 2019 | 18 | 2019 |
| Prevalence of and risk factors for adverse events in Alzheimer’s patients receiving anti-dementia drugs in at-home care H Imai, T Hirai, R Kumazawa, S Nakagawa, A Yonezawa, K Matsubara, ... PloS one 15 (4), e0231226, 2020 | 16 | 2020 |
| Efficacy of protocol‐based pharmacotherapy management on anticoagulation with warfarin for patients with cardiovascular surgery Y Katada, S Nakagawa, K Minakata, M Odaka, H Taue, Y Sato, ... Journal of Clinical Pharmacy and Therapeutics 42 (5), 591-597, 2017 | 16 | 2017 |
